TG Therapeutics Newsroom

TG Therapeutics Price Target Raised to $55.00/Share From $49.00 by HC Wainwright & Co.

Dow JonesNov 6 01:51

TG Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow JonesNov 6 01:51

Goldman Sachs Maintains Neutral on TG Therapeutics, Raises Price Target to $22

BenzingaNov 6 01:27

A Quick Look at Today's Ratings for TG Therapeutics(TGTX.US), With a Forecast Between $38 to $55

Futu NewsNov 5 21:07

TG Therapeutics: Promising Growth Trajectory and Blockbuster Potential Justify Buy Rating

TipRanksNov 5 01:07

TD Cowen Initiates TG Therapeutics(TGTX.US) With Buy Rating, Announces Target Price $50

Futu NewsOct 29 18:31

TD Cowen Initiates TG Therapeutics at Buy With $50 Price Target

MT NewswiresOct 29 17:58

TG Therapeutics Analyst Ratings

BenzingaOct 29 17:53

B.Riley Financial Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $38

Futu NewsOct 25 01:31

H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $49

Futu NewsSep 19 19:31

Analysts' Top Healthcare Picks: TG Therapeutics (TGTX), Boston Scientific (BSX)

TipRanksSep 19 19:06

TG Therapeutics Analyst Ratings

BenzingaSep 19 01:04

HC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $49 Price Target

BenzingaSep 19 01:03

Goldman Sachs Maintains Neutral on TG Therapeutics, Raises Price Target to $20

BenzingaAug 8 00:20

Goldman Sachs Maintains TG Therapeutics(TGTX.US) With Hold Rating, Raises Target Price to $20

Futu NewsAug 7 05:31

Maintaining Hold on TG Therapeutics Amidst Positive Performance and Ongoing Uncertainties

TipRanksAug 7 04:57

HC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $49 Price Target

BenzingaAug 7 02:47

TG Therapeutics Analyst Ratings

BenzingaAug 7 02:45

B.Riley Financial Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $34

Futu NewsAug 7 02:31

H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $49

Futu NewsAug 7 00:31